BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 20368972)

  • 21. Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.
    Selb R; Fuchs V; Graf B; Hamprecht A; Hogardt M; Sedlacek L; Schwarz R; Idelevich EA; Becker SL; Held J; Küpper-Tetzel CP; McCormick-Smith I; Heckmann D; Gerkrath J; Han CO; Wilmes D; Rickerts V
    Int J Med Microbiol; 2019 Sep; 309(6):151336. PubMed ID: 31444102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A defect in iron uptake enhances the susceptibility of Cryptococcus neoformans to azole antifungal drugs.
    Kim J; Cho YJ; Do E; Choi J; Hu G; Cadieux B; Chun J; Lee Y; Kronstad JW; Jung WH
    Fungal Genet Biol; 2012 Nov; 49(11):955-66. PubMed ID: 22975303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole.
    Posteraro B; Sanguinetti M; Sanglard D; La Sorda M; Boccia S; Romano L; Morace G; Fadda G
    Mol Microbiol; 2003 Jan; 47(2):357-71. PubMed ID: 12519188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of Three Cryptococcus neoformans and Cryptococcus gattii Efflux Pump-Coding Genes in Response to Drug Treatment.
    Chang M; Sionov E; Khanal Lamichhane A; Kwon-Chung KJ; Chang YC
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378705
    [No Abstract]   [Full Text] [Related]  

  • 25. Environmental Triazole Induces Cross-Resistance to Clinical Drugs and Affects Morphophysiology and Virulence of Cryptococcus gattii and C. neoformans.
    Bastos RW; Carneiro HCS; Oliveira LVN; Rocha KM; Freitas GJC; Costa MC; Magalhães TFF; Carvalho VSD; Rocha CE; Ferreira GF; Paixão TA; Moyrand F; Janbon G; Santos DA
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109169
    [No Abstract]   [Full Text] [Related]  

  • 26. Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method.
    Pfaller MA; Castanheira M; Diekema DJ; Messer SA; Jones RN
    Diagn Microbiol Infect Dis; 2011 Nov; 71(3):252-9. PubMed ID: 21917395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of environmental factors on sensitivity of Cryptococcus neoformans to fluconazole and amphotericin B.
    Carlson T; Lupinacci E; Moseley K; Chandrasekaran S
    FEMS Microbiol Lett; 2021 May; 368(7):. PubMed ID: 33877319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heteroresistance of Cryptococcus gattii to fluconazole.
    Varma A; Kwon-Chung KJ
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2303-11. PubMed ID: 20385871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
    Hagen F; Hare Jensen R; Meis JF; Arendrup MC
    Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.
    Gago S; Serrano C; Alastruey-Izquierdo A; Cuesta I; Martín-Mazuelos E; Aller AI; Gómez-López A; Mellado E
    Mycoses; 2017 Jan; 60(1):40-50. PubMed ID: 27633849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
    Lamping E; Ranchod A; Nakamura K; Tyndall JD; Niimi K; Holmes AR; Niimi M; Cannon RD
    Antimicrob Agents Chemother; 2009 Feb; 53(2):354-69. PubMed ID: 19015352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Astemizole and an analogue promote fungicidal activity of fluconazole against Cryptococcus neoformans var. grubii and Cryptococcus gattii.
    Vu K; Gelli A
    Med Mycol; 2010 Mar; 48(2):255-62. PubMed ID: 19572230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cloning of the lanosterol 14-α-demethylase ( ERG11 ) gene in Trichosporon asahii: a possible association between G453R amino acid substitution and azole resistance in T. asahii.
    Kushima H; Tokimatsu I; Ishii H; Kawano R; Shirai R; Kishi K; Hiramatsu K; Kadota J
    FEMS Yeast Res; 2012 Sep; 12(6):662-7. PubMed ID: 22621704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cryptococcus neoformans Yap1 is required for normal fluconazole and oxidative stress resistance.
    Paul S; Doering TL; Moye-Rowley WS
    Fungal Genet Biol; 2015 Jan; 74():1-9. PubMed ID: 25445311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluconazole induces ROS in Cryptococcus neoformans and contributes to DNA damage in vitro.
    Peng CA; Gaertner AAE; Henriquez SA; Fang D; Colon-Reyes RJ; Brumaghim JL; Kozubowski L
    PLoS One; 2018; 13(12):e0208471. PubMed ID: 30532246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of VT-1129 against Cryptococcus neoformans clinical isolates with high fluconazole MICs.
    Nielsen K; Vedula P; Smith KD; Meya DB; Garvey EP; Hoekstra WJ; Schotzinger RJ; Boulware DR
    Med Mycol; 2017 Jun; 55(4):453-456. PubMed ID: 27664991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluconazole-Induced Ploidy Change in
    Altamirano S; Fang D; Simmons C; Sridhar S; Wu P; Sanyal K; Kozubowski L
    mSphere; 2017; 2(3):. PubMed ID: 28630940
    [No Abstract]   [Full Text] [Related]  

  • 38. Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya.
    Bii CC; Makimura K; Abe S; Taguchi H; Mugasia OM; Revathi G; Wamae NC; Kamiya S
    Mycoses; 2007 Jan; 50(1):25-30. PubMed ID: 17302744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host Carbon Dioxide Concentration Is an Independent Stress for Cryptococcus neoformans That Affects Virulence and Antifungal Susceptibility.
    Krysan DJ; Zhai B; Beattie SR; Misel KM; Wellington M; Lin X
    mBio; 2019 Jul; 10(4):. PubMed ID: 31266878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans.
    Yamazumi T; Pfaller MA; Messer SA; Houston AK; Boyken L; Hollis RJ; Furuta I; Jones RN
    J Clin Microbiol; 2003 Jan; 41(1):267-72. PubMed ID: 12517859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.